Merck & Co., Inc.
MRK
79.84
USD+1.10
(+1.40%)Day's range
76.03
79.97
52 wk Range
75.93
134.63
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 41,518,000,000 | 48,704,000,000 | 59,283,000,000 | 60,115,000,000 | 64,168,000,000 | |
| Gross Profit | 27,900,000,000 | 35,078,000,000 | 41,872,000,000 | 43,989,000,000 | 51,879,000,000 | |
| Operating Income | 6,076,000,000 | 13,703,000,000 | 19,399,000,000 | 2,954,000,000 | 22,692,000,000 | |
| Net Income | 7,067,000,000 | 13,049,000,000 | 14,519,000,000 | 365,000,000 | 17,117,000,000 | |
| Total Assets | 91,588,000,000 | 105,694,000,000 | 109,160,000,000 | 106,675,000,000 | 77,283,000,000 | |
| Total Current Liabilities | 27,327,000,000 | 23,872,000,000 | 24,239,000,000 | 25,694,000,000 | 28,420,000,000 | |
| Total Equity | 25,404,000,000 | 38,257,000,000 | 46,058,000,000 | 37,635,000,000 | 46,313,000,000 | |
| Free Cash Flow | 5,569,000,000 | 9,661,000,000 | 14,707,000,000 | 9,143,000,000 | 18,096,000,000 | |
| Cash from Operations | 10,253,000,000 | 14,109,000,000 | 19,095,000,000 | 13,006,000,000 | 21,468,000,000 | |
| Cash from Investing | -9,443,000,000 | -16,555,000,000 | -4,960,000,000 | -14,083,000,000 | -7,734,000,000 | |
| Cash from Financing | -2,832,000,000 | 2,593,000,000 | -9,119,000,000 | -4,810,000,000 | -7,032,000,000 | |
| Net Change in Cash | -1,769,000,000 | 14,000,000 | 4,606,000,000 | -5,864,000,000 | 6,409,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy